Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Thursday, June 27, 2024 · 723,304,059 Articles · 3+ Million Readers

Global Muscle Wasting Disorders Market Set for Robust Growth, Expected to Reach $26.11 Billion by 2028

Muscle Wasting Disorders Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

Muscle Wasting Disorders Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033

You Can Now Pre Order Your Report To Get A Swift Deliver With All Your Needs ”
— The Business Research Company

LONDON, GREATER LONDON, UK, June 21, 2024 /EINPresswire.com/ -- The term muscle wasting disorders, also known as muscle atrophy or muscle wasting, encompasses a range of conditions characterized by the progressive loss of muscle mass and strength. These disorders can arise from various factors, including disuse, aging, malnutrition, neurodegenerative diseases, and certain medical conditions.

Market Size and Growth
The muscle wasting disorders market has witnessed rapid growth in recent years, with a projected increase from $12.91 billion in 2023 to $15.06 billion in 2024, representing a compound annual growth rate (CAGR) of 16.6%. This growth can be attributed to factors such as the increasing aging population, rising incidence of chronic diseases, advancements in research and development, increased awareness of early diagnosis, and emerging therapeutic approaches.
In the forecast period, the market is expected to continue its strong growth trajectory, reaching $26.11 billion by 2028, at a CAGR of 14.8%. This growth will be driven by factors such as regulatory support, patient advocacy initiatives, healthcare infrastructure development, globalization of clinical trials, and personalized medicine approaches. Major trends in the forecast period include the adoption of telemedicine, technological advancements in diagnostics, product innovation, collaborations and partnerships, advancements in therapeutics, research on molecular mechanisms, and biopharmaceutical innovation.

Explore comprehensive insights into the global muscle wasting disorders market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=13706&type=smp

Impact of Sedentary Lifestyle
The rise in adherence to a sedentary lifestyle is expected to fuel the growth of the muscle wasting disorders market. A sedentary lifestyle, characterized by physical inactivity and little to no exercise, can negatively impact muscle function, leading to a decline in muscle strength and endurance. This trend makes it challenging for individuals to maintain muscle mass and function, contributing to muscle wasting disorders. According to the World Health Organization, over 80% of adolescents and 27% of adults did not adhere to recommended physical activity levels in 2022, highlighting the significant impact of sedentary behavior on muscle health.

Key Players and Innovations
Major companies operating in the muscle wasting disorders market are focusing on developing innovative products to better serve patients. For example, Sarepta Therapeutics introduced Elevidys, the first gene therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD) in pediatric patients aged 4 to 5 years old. Elevidys is a recombinant gene therapy designed to deliver a gene that leads to a shortened protein containing selected domains of the dystrophin protein of normal muscle cells.

Regional Insights
North America dominated the muscle wasting disorders market in 2023, driven by factors such as technological advancements, favorable regulatory policies, and high healthcare expenditure. However, Asia-Pacific is expected to emerge as the fastest-growing region in the forecast period, fueled by factors such as increasing healthcare infrastructure development, rising disposable income, and a growing patient population.

Market Segmentation
The muscle wasting disorders market covered in this report is segmented –
1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users

Access the complete report for an in-depth analysis of the global muscle wasting disorders market: https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report


Muscle Wasting Disorders Global Market Report 2024 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Muscle Wasting Disorders Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on muscle wasting disorders market size, muscle wasting disorders market drivers and trends, muscle wasting disorders market major players, competitors' revenues, market positioning, and market growth across geographies. The muscle wasting disorders market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Anorectal Disorders Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/anorectal-disorders-treatment-global-market-report

Optic Nerve Disorders Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

Myeloproliferative Disorders Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/myeloproliferative-disorders-drugs-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release